Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial

Objectives To evaluate whether the effectiveness and safety of low (81 mg daily) versus high-dose (325 mg daily) aspirin is consistent across races among patients with established atherosclerotic cardiovascular disease (ASCVD).Design A secondary analysis of the randomised controlled trial ADAPTABLE...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Saket Girotra, Sunil Kripalani, Adrian F Hernandez, Catherine P Benziger, Hillary Mulder, Peter M Farrehi, Lisa M Wruck, Russell Rothman, Guillaume Marquis-Gravel, Jeff Whittle, Kamal Gupta, Mark B Effron, Daniel Muñoz, Tamar S Polonsky, Robert Harrington, WS Jones
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMJ Publishing Group 2024-08-01
Serie:	BMJ Open
Accesso online:	https://bmjopen.bmj.com/content/14/8/e078197.full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!